#Abrysvo #Pfizer #WHO #WorldHealthOrganization #maternalRSVvaccine #RSVprevention #respiratorysyncytialvirus #RSV #RSVvaccine #prequalifiedvaccines #RSVinfection #maternalvaccination #GAVI #Unicef #publichealth #passiveimmunisation
pharmatimes.com/news/who-add...
pharmatimes.com/news/who-add...
WHO adds first maternal RSV vaccine to prequalification list - PharmaTimes
Pfizer’s Abrysvo is designed to prevent RSV-associated disease in infants
pharmatimes.com
March 26, 2025 at 11:15 AM